VS3 Medical announces first patients enrolled
An international first-in-human feasibility study is enrolling patients to evaluate the VS3 Medical Stent System for symptomatic venous sinus stenosis, assessing safety and efficacy at three months.
See the latest news and media coverage for VS3 Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.
Neurovascular medical device company
vs3medical.comLast updated
An international first-in-human feasibility study is enrolling patients to evaluate the VS3 Medical Stent System for symptomatic venous sinus stenosis, assessing safety and efficacy at three months.
SAN JOSE, Calif., March 09, 2026--(BUSINESS WIRE)--VS3 Medical, Inc., a private company developing novel neurovascular implants, today announced it has commenced enrollment in its international...
Track VS3 Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to VS3 Medical and other trending companies.